Antibacterial and Antiviral Series
所属分类: Function Filter Block
Telephone:086-535-2298158
E-mail:xs@xshengcn.com
Category: Function Filter Block
Description
Antibacterial and antiviral series products, using the most advanced antibacterial and antiviral new material research results have been successfully applied to indoor solid pollutants and microorganisms in the depth of the comprehensive purification, the product with high efficiency, high efficiency antibacterial and antiviral, no odor and other advantages, the launch of the market has quickly captured the market, becoming a hot new favorite filtration.
Application fields:
Air filters for air purification in high-speed railways, air filters for air purification in hospital operating rooms/CUs, air filters for air purification in biological laboratories, air filters for air purification in subways and large shopping malls, and so on.
Features:
Highly efficient dust removal I Antibacterial and antiviral materials with highly efficient filter media can efficiently remove PM2.5 from the space;
Highly efficient pollen filtering a highly efficient removal of pollen, pollen filtering efficiency of 99%;
Antibacterial and antiviral-99% antibacterial efficiency, 99% antiviral efficiency;
No odor - no odor before or after use.
Technical Parameters:
Pollen filtration efficiency ≥ 99%
Inhibition rate of E. coli, Staphylococcus aureus ≥ 99%
Influenza A virus (H1N1) antiviral activity rate of ≥ 99%
Enterovirus (EV71) antiviral activity rate of ≥ 99%
Coronavirus (HCoV-229E) antiviral activity rate ≥ 99%
R & D strength
Gathering global wisdom to accelerate innovation engines
We pay attention to product research and development and technological innovation investment, adhere to the underlying technological innovation, and strive to provide strong support for the creation of more valuable purification system solutions through the integration of global innovation resources. A number of core technologies occupy the leading position in the world. The average annual R & D investment is more than 30 million yuan.
R & D and technology integration
After nearly 30 years of development, the company has honed a professional R & D team with more than 30 professional and technical personnel; the products have won the Shandong Provincial Science and Technology Progress Award and the National Key New Product Award for many times.
The company has established long-term and stable cooperative relations with organizations and scientific research institutes such as Darwin, China Center for Disease Control and Prevention, China Academy of Building Sciences, Institute of Chemical Defense of the General Assembly Department, Institute of Aerospace 703, Tongji University, Wuhan University, Tianjin University, Xi'an Jiaotong University and other organizations and scientific research institutes to jointly carry out theoretical research and new product research and development.
High standard laboratory
Xuesheng invested 10 million yuan to build a high-standard testing center, which can conduct full performance testing and evaluation of air purifiers, disinfection machines, air filters, and total heat exchangers. It is also one of the earliest enterprises in the industry to establish a standardized laboratory.
Production strength
Production, from manufacturing to service
We integrate service thinking into all aspects of production, pay attention to customer customization needs, and make production more scientific and efficient through manufacturing and management model innovation.
Advanced and efficient production equipment
We take the personalized customization needs of customers as the focus of production innovation, constantly improve flexible production capacity, increase the proportion of intelligent manufacturing, optimize the process flow, and realize the efficient manufacturing mode of non-standard products.
omni-directional detection
The company always insists on putting product quality first, and strictly controls the quality of all aspects of the process,
Every detail is our focus.
Keywords: Antibacterial and Antiviral Series